Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3020 |
|
| Actual shortage: | 235 (8%) | |
| Anticipated shortage: | 19 (1%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2757 (91%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
28 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-LEVOCARB-TAB 25MG/100MG | 25MG 100MG | TABLET | Resolved | 2021-02-26 | 2021-03-08 | 134817 |
| APO-VALSARTAN/HCTZ | 25MG 160MG | TABLET | Resolved | 2017-03-11 | 2019-03-21 | 546 |
| APO-QUINAPRIL/HCTZ | 25MG 20MG | TABLET | Resolved | 2017-11-28 | 2018-11-02 | 31025 |
| APO-QUINAPRIL/HCTZ | 25MG 20MG | TABLET | Resolved | 2018-11-30 | 2019-03-16 | 68245 |
| APO-QUINAPRIL/HCTZ | 25MG 20MG | TABLET | Resolved | 2019-07-12 | 2019-11-25 | 89167 |
| APO-QUINAPRIL/HCTZ | 25MG 20MG | TABLET | Resolved | 2019-08-21 | 2019-09-16 | 92032 |
| APO-QUINAPRIL/HCTZ | 25MG 20MG | TABLET | Resolved | 2020-03-27 | 2020-09-09 | 109686 |
| APO-QUINAPRIL/HCTZ | 25MG 20MG | TABLET | Actual shortage | 2021-11-05 | 2022-05-09 | 148876 |
| APO-QUINAPRIL/HCTZ | 25MG 20MG | TABLET | Actual shortage | 2022-01-07 | 2022-05-06 | 152332 |
| APO METHAZIDE 25 | 25MG 250MG | TABLET | Actual shortage | 2017-08-13 | 2017-10-05 | 18936 |
| APO-LEVOCARB - TAB 25MG/250MG | 25MG 250MG | TABLET | Resolved | 2017-08-23 | 2017-11-09 | 20108 |
| APO-LEVOCARB - TAB 25MG/250MG | 25MG 250MG | TABLET | Resolved | 2017-10-03 | 2017-11-09 | 24265 |
| APO-LEVOCARB - TAB 25MG/250MG | 25MG 250MG | TABLET | Resolved | 2019-02-06 | 2019-03-01 | 74911 |
| APO-LEVOCARB - TAB 25MG/250MG | 25MG 250MG | TABLET | Resolved | 2020-12-28 | 2021-02-22 | 130710 |
| APO-LEVOCARB - TAB 25MG/250MG | 25MG 250MG | TABLET | Resolved | 2021-03-26 | 2021-05-10 | 136403 |
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Resolved | 2017-10-11 | 2017-11-15 | 25287 |
| APO-VALSARTAN/HCTZ | 25MG 320MG | TABLET | Resolved | 2017-03-11 | 2019-03-21 | 567 |
| APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Resolved | 2017-12-14 | 2018-02-26 | 32772 |
| APO-OLMESARTAN/HCTZ | 25MG 40MG | TABLET | Resolved | 2017-07-25 | 2017-11-17 | 16895 |
| APO-OLMESARTAN/HCTZ | 25MG 40MG | TABLET | Resolved | 2018-01-17 | 2018-04-23 | 36321 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
| APO-CETIRIZINE | Discontinued | 2018-05-31 | 2018-05-31 | 50998 | ||
| APO-AMOXI CLAV 125MG/31.25MG PER 5ML | Discontinued | 2018-09-07 | 2018-09-15 | 60241 | ||
| APO-CYCLOSPORINE ORAL SOLUTION | Discontinued | 2018-09-07 | 2018-09-15 | 60408 | ||
| APO-FAMOTIDINE TAB 20MG USP | Discontinued | 2018-09-07 | 2018-09-15 | 60477 | ||
| APO-FAMOTIDINE TAB 40MG USP | Discontinued | 2018-09-07 | 2018-09-15 | 60480 | ||
| APO-FENTANYL MATRIX | Discontinued | 2018-09-07 | 2018-09-15 | 60494 | ||
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
| APO-LATANOPROST-TIMOP | Discontinued | 2018-09-07 | 2018-09-15 | 60572 | ||
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60735 | ||
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60738 | ||
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60741 | ||
| APO-RIZATRIPTAN RPD | Discontinued | 2018-09-08 | 2019-04-02 | 60756 | ||
| APO-SILDENAFIL R | Discontinued | 2018-09-08 | 2018-09-15 | 60787 | ||
| APO-AMOXI CLAV 125MG/31.25MG PER 5ML | Discontinued | 2018-12-21 | 2018-12-24 | 70347 | ||
| APO-TIMOP | Discontinued | 2019-01-02 | 2019-01-02 | 70818 | ||
| ACID CONTROL | Discontinued | 2019-01-03 | 2019-01-03 | 70906 | ||
| APO-OFLOXACIN | Discontinued | 2019-01-03 | 2019-01-03 | 71017 | ||
| APO-TIMOP GEL | Discontinued | 2019-01-03 | 2019-01-03 | 71020 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71029 |